Alta Bates Summit Medical Center   Report issue

Academic/Hospital Phase 1 Phase 3
Founded: Oakland CA United States (1905)

Organization Overview

First Clinical Trial
2004
NCT00208039
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Alta Bates Summit Medical Center

Active Ingredients

Drugs in Phase 3 Trials (1)

dalfampridine (ampyra) (1 trial)

Drugs in Phase 1 Trials (2)

coconut oil (1 trial)

ketamine (ketalar) (1 trial)

Drugs in Other Trials (2)

calfactant (infasurf) (1 trial)

fish oil (Omegavan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 1)

Congenital Abnormalities (Phase 1)

Dyspareunia (Phase 1)

Dysuria (Phase 1)

Multiple Sclerosis (Phase 3)

Sclerosis (Phase 3)

Urinary Tract Infections (Phase 1)

Urogenital Abnormalities (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 5